In this episode, we’re joined by Jenny Yang, Founder and CEO of Outpost Bio, a company building an AI-driven platform to understand how the human microbiome interacts with drugs, food, and other interventions.
Jenny shares her journey from machine learning and genomics research through to her PhD at the University of Oxford and experience at Exscientia, before founding Outpost Bio.
We discuss why the microbiome remains an underexplored layer in drug discovery, how advances in AI are enabling more complex biological modelling, and the role of high-quality data in building systems that can translate into real-world impact.
